SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Advaxis, Inc. (ADXS)

ADXS RSS Feed
Add ADXS Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, DewDiligence, jaxstraw, gajj
Search This Board:
Last Post: 1/24/2017 12:18:25 AM - Followers: 238 - Board type: Free - Posts Today: 1


 

 

RE-ENGAGING THE IMMUNE SYSTEM TO FIGHT CANCER

Advaxis is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. The Advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (Lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

 

Additional Resources

Company Website
 


Share Structure

 
Shares Outstanding 
 
39,639,000
 

 

 



 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ADXS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ADXS News: Current Report Filing (8-k) 01/09/2017 08:31:28 AM
ADXS News: Advaxis Provides 2017 Business Outlook 01/09/2017 08:00:00 AM
ADXS News: Annual Report (10-k) 01/09/2017 06:39:13 AM
ADXS News: Statement of Changes in Beneficial Ownership (4) 01/03/2017 05:30:50 PM
ADXS News: Statement of Changes in Beneficial Ownership (4) 01/03/2017 05:30:15 PM
PostSubject
#9010  Sticky Note Re: ADXS enterprise value DewDiligence 12/03/16 11:23:17 AM
#8270  Sticky Note Blue, there's no doubt in my mind that hdwrsft 11/15/16 06:52:01 PM
#7252  Sticky Note Full text of cancer-vaccine article from Oct 2016 DewDiligence 10/14/16 03:50:18 PM
#11715   Here's an email I sent to Ranya on mypekeispooped 01/24/17 12:18:25 AM
#11714   It is funny, and it's also precisely the ignatiusrielly35 01/23/17 11:19:16 PM
#11713   I don't necessarily think it's Astra. Most people ignatiusrielly35 01/23/17 11:16:54 PM
#11712   Glad you all agree. I'm holding strong and fbg0316 01/23/17 11:08:49 PM
#11711   I can't disagree with any of that, fbg. Batermere 01/23/17 10:58:24 PM
#11710   I agree without the dilution we would probably obi10 01/23/17 10:53:34 PM
#11709   2017 was on track to be a great fbg0316 01/23/17 10:43:54 PM
#11708   Understand, yet such a funny rationale. dawson-m 01/23/17 10:35:05 PM
#11707   So you think AstraZeneca is the suitor because oakrock 01/23/17 10:33:08 PM
#11706   Some people have the view that somehow a ignatiusrielly35 01/23/17 10:32:46 PM
#11705   "it is obvious the only thing that will dawson-m 01/23/17 10:25:04 PM
#11704   Good thought. They call that "pull" demand in ignatiusrielly35 01/23/17 10:09:57 PM
#11703   No idea but good to see. Just maybe those James salmon 01/23/17 10:04:47 PM
#11702   What might cause a sudden increase in urgency? ignatiusrielly35 01/23/17 10:02:41 PM
#11701   Yes certainly the pace of recruitment should increase James salmon 01/23/17 09:44:44 PM
#11700   What does that signal to you, James? Something ignatiusrielly35 01/23/17 09:41:29 PM
#11699   It's the increase in trial sites that stands James salmon 01/23/17 09:29:34 PM
#11698   Wow, ADXS now has six trials actively recruiting. ignatiusrielly35 01/23/17 09:15:26 PM
#11697   James I read the first article this morning mastiffsforlife 01/23/17 07:56:29 PM
#11696   So why the collective yawn about the new mpreorder 01/23/17 07:47:48 PM
#11695   Fidelity only purchased in August, didn't they? ignatiusrielly35 01/23/17 07:46:15 PM
#11694   http://edition.cnn.com/2017/01/23/health/cervical-cancer-death-study/ James salmon 01/23/17 07:19:47 PM
#11693   Ask DO. Lol. hdwrsft 01/23/17 07:14:25 PM
#11692   Has anyone read or watched all the news mastiffsforlife 01/23/17 07:08:41 PM
#11691   I agree 100%, if Dan and his high obi10 01/23/17 07:04:54 PM
#11690   You found it, Dew. Nice work. ignatiusrielly35 01/23/17 06:49:58 PM
#11689   Try 2020. Nothing going to happen until sd21 01/23/17 06:45:24 PM
#11688   Absolutely "Johnny on the spot"! steadykickin 01/23/17 06:38:31 PM
#11687   This year is a huge year for Advaxis, James salmon 01/23/17 06:30:13 PM
#11686   What?!....what happened to 2017. steadykickin 01/23/17 06:14:59 PM
#11685   This week right? Going to hold you to it. steadykickin 01/23/17 06:10:32 PM
#11684   I stand by my belief that the primary fbg0316 01/23/17 05:40:44 PM
#11683   HER2 trial sites added; https://clinicaltrials.gov/ct2/show/NCT02386501?term=Ad James salmon 01/23/17 05:33:30 PM
#11682   Hmmm....must be that "fake news" we keep hearing about. Julius_Kelp 01/23/17 05:32:03 PM
#11681   Bourbon, the others are right, Fidelity did add cab033 01/23/17 05:31:44 PM
#11680   Merck combo trial sites added; https://clinicaltrials.gov/ct2/show/NCT02325557? James salmon 01/23/17 05:31:36 PM
#11679   Bourbon they added 1.3 million in August in fbg0316 01/23/17 05:31:32 PM
#11678   I don't know if changing of the guard hdwrsft 01/23/17 05:31:11 PM
#11677   Sites added to this trial as well; https://clinicaltrials.gov/ct2/show/NCT02399 James salmon 01/23/17 05:29:57 PM
#11676   Actually there has been a lot of changes James salmon 01/23/17 05:28:49 PM
#11675   I agree 2018 should be our year. I cab033 01/23/17 05:17:03 PM
#11674   also AMGN owns 3 millions shares, and Adage Bourbon_on_my_cornflakes 01/23/17 05:16:52 PM
#11673   Interesting. Your source actually has them adding Bourbon_on_my_cornflakes 01/23/17 05:14:34 PM
#11672   Think they have that shown wrong; Look at this James salmon 01/23/17 05:13:13 PM
#11671   and so does Fidelity ApricotUS 01/23/17 05:12:50 PM
#11670   http://www.nasdaq.com/symbol/adxs/institutional-holdings maplestory 01/23/17 05:10:59 PM
#11669   Don't you just have it when predicted text James salmon 01/23/17 05:10:36 PM
#11668   Morning start have fidelity still owning a ton James salmon 01/23/17 05:09:45 PM
#11667   https://fintel.io/so/us/adxs Bourbon_on_my_cornflakes 01/23/17 04:51:15 PM
#11666   Where did you get that? The Nasdaq website fbg0316 01/23/17 04:50:04 PM
PostSubject